More on ARMP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+44.6% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Armata Pharma (NY:ARMP)
Delayed: 5.58 +0.30 (5.68%)
Prev. Close $5.28  
Open$5.36 
52 Wk High$2.00 
52 Wk Low$1.50 
Day High$5.61 
Day Low$5.27 
P/E N/A  
EPS$0.00 
Volume49,077 


Aug 12, 2026 04:47 PM Armata Pharmaceuticals, Inc. (ARMP) Tops Q2 EPS by 17c
Aug 12, 2026 04:23 PM Form 10-Q Armata Pharmaceuticals, For: Jun 30
Aug 12, 2026 04:17 PM Form 8-K Armata Pharmaceuticals, For: Aug 12
Aug 12, 2026 04:05 PM Armata Pharmaceuticals Announces Financial Results for the Second Quarter 2026 and Provides a Corporate Update
Jul 20, 2026 07:13 AM Form 8-K Armata Pharmaceuticals, For: Jul 20
Jul 20, 2026 07:13 AM Form 8-K Armata Pharmaceuticals, For: Jul 17
Jul 20, 2026 07:00 AM Armata submits Phase 3 protocol to FDA for bacteriophage drug AP-SA02
Jul 20, 2026 07:00 AM Armata Pharmaceuticals Achieves Key Progress Across Clinical, Regulatory and Manufacturing Activities Supporting Planned Phase 3 Initiation of AP-SA02
Jul 14, 2026 04:19 PM Form 4 Armata Pharmaceuticals, For: Jul 10 Filed by: Birx Deborah
Jul 13, 2026 07:12 AM Form 8-K Armata Pharmaceuticals, For: Jul 13
View All Articles

Entities mentioned with ARMP

View All Entities